Platelets stimulate thromboplastin synthesis in human endothelial cells

Area of Science:

• Biochemistry
• Cell Biology
• Hematology

Background:

• Human umbilical vein endothelial cells (HUVEc) synthesize thromboplastin upon stimulation.
• Thromboplastin plays a crucial role in the coagulation cascade.

Purpose of the Study:

• To investigate the role of platelets in thromboplastin synthesis by HUVEc.
• To determine the mechanism and pathophysiological relevance of platelet-mediated thromboplastin enhancement.

Main Methods:

• HUVEc were stimulated with phytohaemagglutinin (PHA) or 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
• The effect of gel-filtered platelets and platelet aggregates on thromboplastin activity was assessed.
• Cycloheximide was used to investigate the necessity of de novo protein synthesis.
• Coagulation assays and antibody neutralization techniques were employed to quantify thromboplastin and apoprotein III.

Main Results:

• Platelets, even at concentrations below physiological levels, significantly enhanced thromboplastin activity in a time-dependent manner.
• The enhancement of thromboplastin activity correlated with the number of platelets added.
• Cycloheximide inhibited this enhancement, indicating de novo synthesis of apoprotein III.
• Monocyte removal abolished thromboplastin activity and apoprotein III antigen in platelet preparations.

Conclusions:

• Platelets potentiate thromboplastin synthesis by endothelial cells, likely through the de novo synthesis of apoprotein III.
• This platelet-endothelial cell interaction may have significant pathophysiological implications in hemostasis and thrombosis.
• The findings underscore the importance of considering platelet-endothelial cell crosstalk in understanding coagulation disorders.